EPM2A p.Val23Leu

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM1PM2BP4

The NM_005670.4(EPM2A):​c.67G>T​(p.Val23Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Synonymous variant affecting the same amino acid position (i.e. V23V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

EPM2A
NM_005670.4 missense

Scores

2
2
15

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.72

Publications

0 publications found
Variant links:
Genes affected
EPM2A (HGNC:3413): (EPM2A glucan phosphatase, laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018]
EPM2A-DT (HGNC:48990): (EPM2A divergent transcript)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005670.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 17 uncertain in NM_005670.4
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31955385).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005670.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPM2A
NM_005670.4
MANE Select
c.67G>Tp.Val23Leu
missense
Exon 1 of 4NP_005661.1O95278-1
EPM2A
NM_001360071.2
c.-603G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 5NP_001347000.1O95278-8
EPM2A
NM_001368131.1
c.-301G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 4NP_001355060.1O95278-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPM2A
ENST00000367519.9
TSL:1 MANE Select
c.67G>Tp.Val23Leu
missense
Exon 1 of 4ENSP00000356489.3O95278-1
EPM2A
ENST00000435470.2
TSL:1
c.67G>Tp.Val23Leu
missense
Exon 1 of 5ENSP00000405913.2O95278-2
EPM2A
ENST00000638262.1
TSL:1
c.67G>Tp.Val23Leu
missense
Exon 1 of 3ENSP00000492876.1O95278-5

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1106734
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
533884
African (AFR)
AF:
0.00
AC:
0
AN:
22652
American (AMR)
AF:
0.00
AC:
0
AN:
16888
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15836
East Asian (EAS)
AF:
0.00
AC:
0
AN:
22564
South Asian (SAS)
AF:
0.00
AC:
0
AN:
33808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21916
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2974
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
927134
Other (OTH)
AF:
0.00
AC:
0
AN:
42962
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Uncertain
0.064
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
17
DANN
Benign
0.85
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.73
T
M_CAP
Pathogenic
0.90
D
MetaRNN
Benign
0.32
T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
1.9
L
PhyloP100
1.7
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
-0.050
N
REVEL
Benign
0.18
Sift
Benign
0.59
T
Sift4G
Benign
0.91
T
PromoterAI
-0.060
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
gMVP
0.34
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

hg19: chr6-146056568;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.